Zepodox 250 Tablet contains Cefuroxime 250 mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exhibiting bactericidal activity. It is indicated for the treatment of various infections caused by susceptible strains of bacteria, including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. Zepodox 250 is also used in the management of acute otitis media and sinusitis. The tablet formulation ensures convenient oral administration with good bioavailability. Cefuroxime is generally well-tolerated; however, potential adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, as well as hypersensitivity reactions in patients with a history of penicillin or cephalosporin allergy. Dosage and duration of therapy should be determined based on the severity and type of infection, as well as patient-specific factors including renal function. It is essential to complete the full prescribed course to prevent the development of resistance. Zepodox 250 should be used under medical supervision with appropriate microbiological guidance where possible.